Dr. Stuart Mair's headshot

Dr. Stuart Mair

Vice President, Medical Consulting

About

Dr. Stuart (Stu) Mair has over 16 years of experience delivering exploratory clinical studies in the contract research organization (CRO) industry. 

Stuart has advised clients on multiple study types, from simple pharmacokinetic (PK), bioequivalence (BE), and characterization studies to complex and flexible designs with multiple portions delivered under a single protocol. He has delivered over 100 first-in-human studies and is an expert in the design and implementation of exploratory clinical trials from FIH to proof of concept (POC) in patient groups with pharmacodynamic (PD) biomarkers.

Prior to joining Quotient Sciences, Stuart was the Medical Director at Charles River Laboratories. He holds a MBChB (Bachelor of Medicine and Bachelor of Surgery) degree and DRCOG (Diploma of the Royal College of Obstetricians and Gynaecologists), DCPSA (Diploma in Clinical Pharmacology of the Society of Apothecaries), and MFPM (Membership of the Faculty of Pharmaceutical Medicine) credentials from the University of Aberdeen in the UK.

Expertise & focus areas

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Translational Pharmaceutics®, Dr. Asma Patel, Matt Paterson Dr. Asma Patel and Matt Pa­terson contribute to Drug Development & Delivery's special feature, 'Outsourcing Formulation Development & Manufacturing' By: Dr. Asma Patel and Matt Paterson
Read More
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
Get in touch
Humanity can't afford to wait, so neither can we.